We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$5.73M
Cap. Flow
-$179K
Cap. Flow %
-0.14%
Top 10 Hldgs %
31.6%
Holding
141
New
11
Increased
30
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.64M
2
NWL icon
Newell Brands
NWL
+$1.16M
3
META icon
Meta Platforms (Facebook)
META
+$1.05M
4
AAPL icon
Apple
AAPL
+$1.02M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1,000K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.2M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$1.44M
3
VSAT icon
Viasat
VSAT
+$1.26M
4
IEV icon
iShares Europe ETF
IEV
+$1.17M
5
NVS icon
Novartis
NVS
+$1.07M

Sector Composition

Rank Sector Weight
1 Miscellaneous 17.42%
2 Technology 15.72%
3 Real Estate 14.11%
4 Healthcare 13.29%
5 Financials 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
51
Walmart Inc
WMT
$817B
$906K 0.69%
31,725
– –
RILYG
52
DELISTED
B. Riley Financial, Inc. 7.25% Senior Notes due 2027
RILYG
$888K 0.67%
+35,600
New +$884K
JNJ icon
53
Johnson & Johnson
JNJ
$640B
$886K 0.67%
7,298
+3,200
+78% +$399K
RDS.A
54
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$886K 0.67%
12,800
– –
PG icon
55
Procter & Gamble
PG
$333B
$781K 0.59%
+10,000
New +$753K
SSW.PRD
56
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
$760K 0.57%
30,050
– –
CMCSA icon
57
Comcast
CMCSA
$93.7B
$747K 0.56%
+22,775
New +$742K
KW
58
DELISTED
Kennedy-Wilson Holdings
KW
$719K 0.54%
34,000
+1,500
+5% +$29.4K
DIAX
59
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$702K 0.53%
38,006
-1,487
-4% -$28K
COP icon
60
ConocoPhillips
COP
$156B
$672K 0.51%
9,650
– –
RWT
61
Redwood Trust
RWT
$582M
$596K 0.45%
36,166
-2,500
-6% -$40.1K
RGLD icon
62
Royal Gold
RGLD
$22.8B
$576K 0.44%
6,200
– –
OHI icon
63
Omega Healthcare
OHI
$14B
$574K 0.43%
18,525
-600
-3% -$17.1K
MS.PRA icon
64
Morgan Stanley Series A Preferred Stock
MS.PRA
$756M
$566K 0.43%
24,205
+2,000
+9% +$45.5K
MET.PRA icon
65
MetLife Inc Floating Rate Series A
MET.PRA
$507M
$553K 0.42%
21,800
– –
RDI icon
66
Reading International Class A
RDI
$48.1M
$536K 0.41%
33,600
+1,000
+3% +$15.9K
DEM icon
67
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
$527K 0.4%
12,299
-1,600
-12% -$73.2K
CTSH icon
68
Cognizant
CTSH
$28.7B
$509K 0.38%
6,450
– –
DOC icon
69
Healthpeak Properties
DOC
$14.6B
$497K 0.38%
19,250
-2,300
-11% -$54.2K
AGIG
70
Abundia Global Impact Group
AGIG
$42.8M
$474K 0.36%
12,472
– –
XLE icon
71
State Street Energy Select Sector SPDR ETF
XLE
$40.9B
$472K 0.36%
12,436
+800
+7% +$29.7K
ROIC
72
DELISTED
Retail Opportunity Investments Corp.
ROIC
$460K 0.35%
24,000
– –
SAFE
73
Safehold
SAFE
$1.09B
$440K 0.33%
8,372
-780
-9% -$40.2K
BRK.B icon
74
Berkshire Hathaway Class B
BRK.B
$1.08T
$429K 0.32%
2,300
– –
NES
75
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$429K 0.32%
35,758
-2,414
-6% -$37.2K
1 2
3
4 5

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Benchmark Capital Advisors held 141 positions worth $132M, up 4.5% from $127M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Benchmark Capital Advisors's Q2 2018 filing shows 11 new, 30 increased, 56 reduced and 10 closed positions. Its largest new stake was Merck: 29,082 shares worth $1.68M. The largest sale was Bristol-Myers Squibb, an estimated $2.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 20% a quarter earlier, followed by Technology and Real Estate.

  • Benchmark Capital Advisors's largest Q2 2018 buy was Merck: 29,082 shares worth $1.68M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.05M increase.
  • Benchmark Capital Advisors's biggest Q2 2018 reduction was Bristol-Myers Squibb, cutting an estimated $2.2M.
  • Benchmark Capital Advisors fully exited Viasat in Q2 2018, selling an estimated $1.26M.
  • Benchmark Capital Advisors's ten largest holdings make up 32% of its $132M portfolio in Q2 2018.
  • Benchmark Capital Advisors opened 11 new positions and closed 10 in Q2 2018.
  • Benchmark Capital Advisors's portfolio value rose 4.5% quarter-over-quarter to $132M.

Based on Benchmark Capital Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.